How Effective Is Misoprostol Alone for Medication Abortion?

NEJM evidence Pub Date : 2024-06-01 Epub Date: 2024-05-28 DOI:10.1056/EVIDccon2300129
Heidi Moseson, Ruvani Jayaweera, Sarah E Baum, Caitlin Gerdts
{"title":"How Effective Is Misoprostol Alone for Medication Abortion?","authors":"Heidi Moseson, Ruvani Jayaweera, Sarah E Baum, Caitlin Gerdts","doi":"10.1056/EVIDccon2300129","DOIUrl":null,"url":null,"abstract":"<p><p>AbstractWith recent severe restrictions to abortion accessibility in the United States and a pending Supreme Court case challenging the Food and Drug Administration's approval of mifepristone, evidence-based strategies to protect and expand access to abortion care are needed. Two safe and effective regimens for medication abortion are widely used globally - misoprostol-only and misoprostol in combination with mifepristone. However, misoprostol-only regimens are rarely used in the United States. In 2023, the National Abortion Federation and the Society of Family Planning updated their recommended protocol for misoprostol-only for medication abortion to 800 μg of misoprostol administered buccally, sublingually, or vaginally every 3 hours for three or more doses. To characterize the data supporting this specific regimen, this article reviews the relevant literature to address the question of how effective misoprostol-only is for medication abortion. The authors conclude that the updated misoprostol regimen is highly effective and a potential strategy for expanding access to abortion.</p>","PeriodicalId":74256,"journal":{"name":"NEJM evidence","volume":"3 6","pages":"EVIDccon2300129"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NEJM evidence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1056/EVIDccon2300129","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/28 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

AbstractWith recent severe restrictions to abortion accessibility in the United States and a pending Supreme Court case challenging the Food and Drug Administration's approval of mifepristone, evidence-based strategies to protect and expand access to abortion care are needed. Two safe and effective regimens for medication abortion are widely used globally - misoprostol-only and misoprostol in combination with mifepristone. However, misoprostol-only regimens are rarely used in the United States. In 2023, the National Abortion Federation and the Society of Family Planning updated their recommended protocol for misoprostol-only for medication abortion to 800 μg of misoprostol administered buccally, sublingually, or vaginally every 3 hours for three or more doses. To characterize the data supporting this specific regimen, this article reviews the relevant literature to address the question of how effective misoprostol-only is for medication abortion. The authors conclude that the updated misoprostol regimen is highly effective and a potential strategy for expanding access to abortion.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
药物流产单用米索前列醇的效果如何?
摘要美国最近对人工流产的可及性进行了严格限制,而且最高法院正在审理一宗挑战美国食品和药物管理局批准米非司酮的案件,因此需要采取循证策略来保护和扩大人工流产护理的可及性。全球广泛使用两种安全有效的药物流产方案--纯米索前列醇和米索前列醇联合米非司酮。然而,在美国,仅使用米索前列醇的方案却很少使用。2023 年,美国国家人工流产联合会和计划生育协会更新了药物流产仅使用米索前列醇的推荐方案,改为每 3 小时口腔、舌下或阴道给药 800 μg 米索前列醇,连续给药 3 次或更多。为了描述支持这一特定方案的数据,本文回顾了相关文献,以探讨只用米索前列醇进行药物流产的效果如何这一问题。作者的结论是,更新后的米索前列醇方案非常有效,是扩大人工流产途径的潜在策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Blood Pressure Targets for Adults with Vasodilatory Shock - An Individual Patient Data Meta-Analysis. BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder. A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis. Treating Patients, Not P Values. A 50-Year-Old Man with Left-Sided Weakness and Difficulty Speaking Clearly.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1